157 related articles for article (PubMed ID: 21882004)
1. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.
Feng F; Wu Y; Wu Y; Nie G; Ni R
J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004
[TBL] [Abstract][Full Text] [Related]
2. A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
Yu Z; Lu H; Si H; Liu S; Li X; Gao C; Cui L; Li C; Yang X; Yao X
PLoS One; 2015; 10(5):e0125517. PubMed ID: 25996920
[TBL] [Abstract][Full Text] [Related]
3. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
4. Application of artificial neural network model combined with four biomarkers in auxiliary diagnosis of lung cancer.
Duan X; Yang Y; Tan S; Wang S; Feng X; Cui L; Feng F; Yu S; Wang W; Wu Y
Med Biol Eng Comput; 2017 Aug; 55(8):1239-1248. PubMed ID: 27766520
[TBL] [Abstract][Full Text] [Related]
5. Development of a machine learning-based multimode diagnosis system for lung cancer.
Duan S; Cao H; Liu H; Miao L; Wang J; Zhou X; Wang W; Hu P; Qu L; Wu Y
Aging (Albany NY); 2020 May; 12(10):9840-9854. PubMed ID: 32445550
[TBL] [Abstract][Full Text] [Related]
6. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
Lin Y; Li H; Huang M; Yin Z; Wu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
8. A Staging Auxiliary Diagnosis Model for Nonsmall Cell Lung Cancer Based on the Intelligent Medical System.
Wu J; Gou F; Tan Y
Comput Math Methods Med; 2021; 2021():6654946. PubMed ID: 33628327
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and prediction of lung cancer through different classification techniques with tumor markers].
Nie GJ; Feng FF; Wu YJ; Wu YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2009 May; 27(5):257-61. PubMed ID: 19538834
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration.
Ayer T; Alagoz O; Chhatwal J; Shavlik JW; Kahn CE; Burnside ES
Cancer; 2010 Jul; 116(14):3310-21. PubMed ID: 20564067
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Beinert T; Fürst H; Fink U
Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
[TBL] [Abstract][Full Text] [Related]
12. [Value of auto-fluorescence spectrum combined with tumor markers in diagnosis of lung cancer].
Wu YJ; Hao YH; Wu WC; Wu YM
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Oct; 29(10):2787-91. PubMed ID: 20038061
[TBL] [Abstract][Full Text] [Related]
13. Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor.
Liu J; Zheng S; Yu JK; Zhang JM; Chen Z
J Zhejiang Univ Sci B; 2005 Jan; 6(1):4-10. PubMed ID: 15593384
[TBL] [Abstract][Full Text] [Related]
14. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
Zhang Z; Barnhill SD; Zhang H; Xu F; Yu Y; Jacobs I; Woolas RP; Berchuck A; Madyastha KR; Bast RC
Gynecol Oncol; 1999 Apr; 73(1):56-61. PubMed ID: 10094881
[TBL] [Abstract][Full Text] [Related]
15. Computerized analysis of cellular features and biomarkers for cytologic diagnosis of early lung cancer.
Qian W; Zhukov T; Song D; Tockman MS
Anal Quant Cytol Histol; 2007 Apr; 29(2):103-11. PubMed ID: 17484274
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
Bergman B; Brezicka FT; Engström CP; Larsson S
Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity and specificity of laser-induced autofluorescence spectra for detection of colorectal cancer with an artificial neural network.
Kwek LC; Fu S; Chia TC; Diong CH; Tang CL; Krishnan SM
Appl Opt; 2005 Jul; 44(19):4004-8. PubMed ID: 16004047
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
Ni LF; Liu XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
[TBL] [Abstract][Full Text] [Related]
19. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
[TBL] [Abstract][Full Text] [Related]
20. Artificial neural network-based diagnostic models for lung cancer combining conventional indicators with tumor markers.
Luo Y; Yuan H; Pei Q; Chen Y; Xian J; Du R; Ye T
Exp Biol Med (Maywood); 2023 May; 248(10):829-838. PubMed ID: 37403334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
